Larry Ramer

Larry Ramer

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

Cardano Price Predictions: Can the ADA Crypto Climb Back Above 50 Cents?

Cardano price predictions are in demand today as the popular altcoin falls below a key 50-cent level. Here's what the experts think.

Cannabis Stocks ACB, CGC, TLRY Fall as Earnings Disappoint

Cannabis stocks are sinking today after Canopy Growth's Q4 revenue came in below analysts' average outlook.

Ford Stock Is Simply Too Cheap to Ignore

F stock has strong positive and negative catalysts, but Ford's valuation is very attractive at this point.

Ethereum Price Predictions: Will Ethereum Recover?

Ethereum has tumbled below the key $2,000 threshold today. However, some websites are still issuing bullish Ethereum price predictions.

NVDA Stock Stumbles as Nvidia Earnings Disappoint

NVDA stock is retreating after the chip maker's Q2 revenue guidance came in below analysts' average estimate.

Sell Coinbase Stock Before Crypto’s Woes Pull It Down Further

A dismal first quarter and further looming disaster for crypto mean that you should sell COIN stock now if you're holding it.

Cathie Wood Just Bought ROKU Stock on the Dip

Cathie Wood bought ROKU stock on weakness yesterday, making the name one of the largest holdings of her firm's ETFs.

Why Is Verrica Pharmaceuticals (VRCA) Stock Plunging 55% Today?

VRCA stock is sinking over 50% in morning trading after the FDA declined to approve the company's treatment for "a viral skin disease."

Zoom (ZM) Stock Climbs on Q1 Earnings Beat

Zoom delivered beat-and-raise results, causing ZM stock to advance slightly despite stock markets' declines today.

ABNB Stock Dips as Airbnb Exits China Business

ABNB stock is dropping after Airbnb said that it intends to stop hosting listings for properties based in mainland China within a few months.